<DOC>
	<DOCNO>NCT02845089</DOCNO>
	<brief_summary>A retrospective observational longitudinal medical chart review study randomly sample patient diagnose advanced/metastatic NSCLC . The minimum observational period patient 12 month .</brief_summary>
	<brief_title>Treatment Patterns , Outcomes Resource Use Study Advanced Stage Non-Small Cell Lung Cancer ( Squamous Non-squamous ) Kingdom Saudi Arabia United Arab Emirates</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Adults 18 year old time advanced/metastatic NSCLC diagnosis , currently alive decease Histologically confirm diagnosis advanced/metastatic NSCLC ( squamous , nonsquamous NOS ) stag IIIB/IV . First diagnosis advanced/metastatic NSCLC 01Jan2010 31Mar2014 ( currently alive decease ) minimum 12 month potential observation period available medical record Medical history treatment data must available ( obtainable SI ) chart abstraction date advanced/metastatic diagnosis recent patient followup/contact . This also include documentation treatment physician inpatient hospital treatment within KSA Health Authority Abu Dhabi ( HAAD ) system Patients must least data age , gender , date advance NSCLC diagnosis , Line Treatment ( LOT ) information ( agent type dosage ) , date last followup Patient enrol cancer treatmentrelated clinical study time diagnosis advanced/metastatic NSCLC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>